Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 68 announcements

Zydus Lifesciences Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,153.00
Market cap: ₹1,16,019 Cr
Revenue (annual): ₹27,148 Cr
Net profit (annual): ₹5,040 Cr
P/E (TTM): 25.7×Sector 47.3×
Promoter holding: 75.01%+0.01% QoQ
FII holding: 6.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 4 Other Announcement 2 Earnings Call 2 Promoter Buying (Off-Market) 1 Product Launch 1 Merger & Restructuring 1 Management Change 1 Legal & Regulatory 1 Financial Results 1 Credit Rating 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

26 Aug 2026 11:12 IST NSE

Merger & Restructuring

Zydus Lifesciences Merger & Restructuring Worth ₹5 Cr

Zydus Lifesciences Limited has incorporated a wholly owned subsidiary, Zydus Global Treasury Centre IFSC Limited, in GIFT City, Gujarat. The subsidiary has a paid-up capital of Rs. 5 Crore.

Value: ₹5.00 Cr

Read the filing ↗